Renalytix AI plc
("RenalytixAI" or the "Company")
Director Dealing
The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 103 pence per share.
Following this purchase, Mr Mills is interested in 9,196,400 Ordinary Shares representing 17.09% of the total voting rights in the Company.
Enquiries:
|
Renalytix AI plc |
|
|
James McCullough, CEO |
Via Walbrook PR or Tel: +1 646 397 3970 |
|
N+1 Singer (Nominated Adviser & Broker) |
Tel: 020 7496 3000 |
|
Aubrey Powell / James White / George Tzimas (Corporate Finance) |
|
|
Tom Salvesen / Mia Gardner (Corporate Broking) |
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 |
|
or renalytix@walbrookpr.com |
|
|
Paul McManus / Lianne Cawthorne |
Mob: 07980 541 893 / 07584 391 303 |
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||
|
a) |
Name |
Harwood Capital LLP (Harwood) as investment manager to NASCIT |
|||
|
2 |
Reason for the notification |
||||
|
a) |
Position/status |
Christopher Mills, non-executive director of the issuer and director of North Altantic Smaller Companies Investment Trust plc (NASCIT) |
|||
|
b) |
Initial notification /Amendment |
Initial notification |
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
Renalytix AI Plc |
|||
|
b) |
LEI |
213800NTOH3FK3WER551 |
|||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 0.25 pence each |
|||
|
Identification code |
GB00BYWL4Y04 |
||||
|
b) |
Nature of the transaction |
Purchase of shares |
|||
|
c) |
Price(s) and volume(s) |
||||
|
Price(s) |
Volume(s) |
||||
|
103 pence |
5,970 |
||||
|
d) |
Aggregated information |
N/A |
|||
|
- Aggregated volume |
|||||
|
- Price |
|||||
|
e) |
Date of the transaction |
19 December 2018 |
|||
|
f) |
Place of the transaction |
London Stock Exchange |
|||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.